AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 192.47 billion as of May 13, 2025. Its market cap has increased by 44.82% in one year.

Market Cap

192.47B

Enterprise Value

168.48B

Revenue

3.36B

Ranking

n/a

PE Ratio

n/a

Stock Price

7,110.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 192.47B, a decrease of -54.53%. That is a compound annual growth rate of -12.46%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	192.47B	12.40%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	563.64B	49.70%
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.02T
Celltrion	33.69T
ALTEOGEN	18.39T
Yuhan	8,026.78B
HLB Co., Ltd.	7,581.42B
SK Biopharmaceuticals	7,079.52B
PharmaResearch	4,171.44B
Peptron	3,872.02B

Market Cap Rankings